We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$127M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$126M
3
CP icon
Canadian Pacific Kansas City
CP
+$122M
4
SKIN icon
SkinHealth Systems
SKIN
+$90.5M
5
AMD icon
Advanced Micro Devices
AMD
+$81.8M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$210M
2
PARA
Paramount Global Class B
PARA
+$187M
3
XYZ
Block Inc
XYZ
+$111M
4
DHR icon
Danaher
DHR
+$109M
5
MNST icon
Monster Beverage
MNST
+$101M

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPSC icon
1301
Century Therapeutics
IPSC
$377M
$2.81M 0.01%
111,552
+58,803
+111% +$1.59M
CLIM
1302
DELISTED
Climate Real Impact Solutions II Acquisition Corporation
CLIM
$2.81M 0.01%
286,780
+96,741
+51% +$943K
GCMG icon
1303
GCM Grosvenor
GCMG
$756M
$2.8M 0.01%
243,268
-976,603
-80% -$10.6M
AMK
1304
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$2.8M 0.01%
+112,547
New +$2.9M
AUROW
1305
CALL
Aurora Innovation Warrant
AUROW
$388M
$2.8M 0.01%
281,749
+156,756
+125% +$234K
BPMC
1306
DELISTED
Blueprint Medicines
BPMC
$2.79M 0.01%
27,105
-11,981
-31% -$1.12M
ITQ
1307
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$2.79M 0.01%
285,608
+185,614
+186% +$1.79M
PTRAW
1308
CALL
DELISTED
Proterra Inc. Warrant
PTRAW
$2.78M 0.01%
274,996
– –
NPWR icon
1309
NET Power
NPWR
$128M
$2.77M 0.01%
+279,714
New +$2.74M
HUGS.WS
1310
CALL
DELISTED
USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
HUGS.WS
$2.77M 0.01%
284,867
– –
TCOM icon
1311
Trip.com Group
TCOM
$28.2B
$2.76M 0.01%
89,721
-380,526
-81% -$10.9M
NEM icon
1312
CALL
Newmont
NEM
$98.5B
$2.76M 0.01%
50,800
+41,000
+418% +$2.42M
HPE icon
1313
Hewlett Packard
HPE
$63.8B
$2.75M 0.01%
193,230
+156,921
+432% +$2.27M
ACH
1314
DELISTED
Alum Corp of China Ltd
ACH
$2.75M 0.01%
147,136
+118,134
+407% +$1.98M
SPRY icon
1315
ARS Pharmaceuticals
SPRY
$572M
$2.75M 0.01%
+275,567
New +$6.8M
ACQRW
1316
CALL
DELISTED
Independence Holdings Corp. Warrant
ACQRW
$2.74M 0.01%
279,997
– –
MGA icon
1317
Magna International
MGA
$18.3B
$2.73M 0.01%
36,349
-78,862
-68% -$6.49M
SPNS
1318
DELISTED
Sapiens International
SPNS
$2.73M 0.01%
94,866
+23,417
+33% +$641K
AEACW
1319
CALL
DELISTED
Authentic Equity Acquisition Corp. Warrant
AEACW
$2.73M 0.01%
281,794
+106,800
+61% +$79.7K
MPLN.WS
1320
CALL
DELISTED
MultiPlan Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MPLN.WS
$2.73M 0.01%
484,997
+60,000
+14% +$89K
LGACW
1321
CALL
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$2.72M 0.01%
279,830
– –
OCAXW
1322
CALL
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
$2.72M 0.01%
274,997
+100,000
+57% +$58.5K
GSQD.WS
1323
CALL
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
$2.72M 0.01%
275,497
+68,694
+33% +$72.1K
CTAC.WS
1324
CALL
DELISTED
Cerberus Telecom Acquisition Corp. Warrants included as part of the Units, each whole warrant exerci
CTAC.WS
$2.72M 0.01%
347,927
+14,600
+4% +$18.7K
RTP.WS
1325
CALL
DELISTED
Reinvent Technology Partners Redeemable Warrants, each whole warrant exercisable for one Class A ord
RTP.WS
$2.72M 0.01%
270,000
-28,001
-9% -$49.4K
51 52
53
54 55

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.